New psychiatric drugs low priority for pharmaceutical firms
New psychiatric drugs low priority for pharmaceutical firms: The pharmaceutical industry has largely abandoned drug development for mental illnesses even though depression is a leading cause of disability, experts say. Authors of papers published in this week's issue of the journal Science Translational Medicine ...